Patent · US Expired

Phenidate drug formulations having diminished abuse potential

US6528530B2 · kind B2 · utility

86Cited by
17References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2001
Grant dateMar 4, 2003
Priority date—
Expiry dateSep 18, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P41/006
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Phenidate drug formulations are provided having reduced potential for drug abuse. Dosage forms for treating Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, AIDS Dementia Complex and cognitive decline in HIV-AIDS are provided which minimize drug hypersensitivity, toxicity, side effects, euphoric effect, and drug abuse potential. Such dosage forms comprise D-threo stereoisomer of a phenidate in the substantial absence of all other stereoisomers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.